一个有针对性和响应性的纳米药物输送系统,用于协同作用的质瘤化疗
Weiling Zhuo1, Wanyu Wang1, Wenjie Zhou2,3
1Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.
这项研究开发了一种新的纳米粒子系统,用于为质瘤治疗提供多克索鲁比 (DOX). 该系统增强了跨血脑屏障的药物输送,克服了药物耐药性,降低了毒性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 多克索鲁比 (DOX) 是一种强效的化疗药物,具有治疗质瘤的潜力.
- 重要的挑战包括DOX毒性,耐药性和血脑屏障 (BBB).
研究的目的:
- 开发一种对谷氨 (GSH) 敏感,积极向的纳米药物输送系统,用于增强质瘤治疗.
- 为了克服DOX耐药性和减少系统性毒性.
主要方法:
- 设计了一种二硫化物结合桥接的DOX前药物 (PEG-SS-DOX),用于GSH的特定释放.
- 结合黄素作为P-糖蛋白 (P-gp) 抑制剂,以增强细胞的DOX吸收.
- 利用cRGD用于主动准,并创建了cRGD/PSDOX-Cur@NPs.
主要成果:
- cRGD/PSDOX-Cur@NPs在体外显示出协同作用的抗瘤作用.
- 在体内研究证实了优越的BBB透和脑准能力.
- 该系统有效地治疗了皮下质瘤和正管质瘤.
结论:
- 开发的纳米药物输送系统显示了对质瘤治疗的巨大潜力.
- 它有效地解决了耐药性和全身毒性的挑战.
- 这种方法为抑制质瘤生长提供了一个新的策略.
更多相关视频
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
